Pasar al contenido principal

DIANAS FARMACOLOGICOS EN LAS DECISIONES DEL DESTINO DE LAS CELULAS MADRE NEURALES: IMPLICACIONES PARA LA REGENERACION

PID2023-146945NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD AUTONOMA DE MADRID

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Down-regulation of neuroprotective protein kinase D in Huntington¿s disease

  • Sebastián-Serrano, Álvaro
  • Simón-García, Ana
  • Santos-Galindo, María
  • Sánchez-Carralero, Marina Prudencio
  • Hernández Alcántara, Alberto
  • Clemente, Cristina
  • Pose-Utrilla, Julia
  • Campanero, Miguel R.
  • Porlan, Eva
  • Lucas, José J.
  • Iglesias, Teresa
Huntington’s disease (HD) is a progressive, autosomal dominant neurodegenerative disorder characterized by the selective dysfunction and loss of neurons in the striatum and cerebral cortex. Experimental evidence suggests that GABAergic medium-sized spiny neurons (MSNs) in the striatum are particularly vulnerable to glutamate-induced toxicity (excitotoxicity) and its analogues. However, the molecular mechanisms underlying MSN-specific death in HD remain poorly understood. The serine/threonine protein kinase D1 (PKD1) confers neuroprotection in various neuropathological conditions, including ischemic stroke. While excitotoxicity inactivates PKD1 in cortical glutamatergic neurons without altering its levels, active PKD1 potentiates the survival of excitatory neurons in highly excitotoxic environments. Here, we investigated whether PKD1 activity dysregulation contributes to MSN death in HD and its association with neurodegeneration. We found an unexpected reduction in PKD1 protein levels in striatal neurons from HD patients. Similarly, the R6/1 mouse model of HD exhibited progressive PKD1 protein loss, commencing at early disease stages, accompanied by decreased Prkd1 transcript levels. PKD1 downregulation also occurred in the cerebral cortex of R6/1 mice, but only at late stages. Functionally, pharmacological PKD inhibition in primary striatal neurons exacerbated excitotoxic damage and apoptosis induced by glutamate N-methyl D-aspartate (NMDA) receptors, whereas expression of constitutively active PKD1 (PKD1-Ca) conferred neuroprotection. Furthermore, PKD1-Ca protected against polyQ-induced apoptosis in a cellular model of HD. In a translational approach, intrastriatal lentiviral delivery of PKD1-Ca in symptomatic R6/1 mice prevented the loss of DARPP-32, a molecular marker of MSNs. Collectively, our findings strongly suggest that PKD1 loss-of-function contributes to HD pathogenesis and the selective vulnerability of MSNs. These findings position PKD1 as a promising therapeutic target for mitigating MSN death in HD., This work was funded by grants PID2020-115218RB-I00 to TI and PID2021-123141OB-I00 to JJL, funded by MCIN/AEI/ 10.13039/501100011033; PID2023-153284OB-100 to TI, PID2023-152367OB-I00 to MRC and PID2023-146945NB-I00 to EP, funded by MCIU/AEI/ 10.13039/501100011033 and by ERDF/EU; and collaborative grants CIBERNED-2018/06 and 2022/03 to TI and JJL funded by Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED, Instituto de Salud Carlos III, Spain). AS-S was funded by a contract from CIBERNED-2018-06 collaborative project and is recipient of a Ramon y Cajal contract, reference RYC2022-035922-I, funded by MCIN/AEI/10.13039/501100011033 and Fondo Social Europeo Plus (FSE + ). AS-G and MPS-C were supported by contracts associated to PID2020-115218RB-I00 and PID2023-153284OB-100 grants. JP-U acknowledges a Juan de la Cierva fellowship from MCIN/AEI (FJC2021-046999-I). The cost of this publication has been paid in part by “ERDF A way of making Europe” funds.